Quick Answer
Lexaria Bioscience Corp. reported Gross Profit of $703.2 thousand for fiscal year 2025.
Lexaria Bioscience Corp. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $703.2K | +53.1% |
| 2024 | $459.5K | +136.0% |
| 2023 | $194.7K | -63.8% |
| 2023 | $538.3K | +193.3% |
| 2022 | $183.6K | -66.5% |
| 2021 | $547.4K | +154.1% |
| 2020 | $215.4K | +7.9% |
| 2019 | $199.7K | -51.1% |
| 2018 | $408.1K | +1104.2% |
| 2017 | $33.9K | +792.0% |
| 2016 | -$4.9K | +67.7% |
| 2015 | -$15.2K | — |
| 2014 | $0.00 | -100.0% |
| 2013 | $302.3K | -47.4% |
| 2012 | $574.5K | +23.3% |
| 2011 | $465.9K | +424.3% |
| 2010 | $88.9K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | $0.00 | -100.0% | -100.0% |
| May 31, 2025 | $174.0K | +107.1% | +0.0% |
| February 28, 2025 | $174.0K | +20.0% | -4.0% |
| November 30, 2024 | $181.2K | +23.7% | +115.7% |
| May 31, 2024 | $84.0K | +29.3% | -42.1% |
| February 29, 2024 | $145.0K | +749.6% | -1.0% |
| November 30, 2023 | $146.5K | +78.7% | +125.5% |
| May 31, 2023 | $65.0K | -19.9% | -44.8% |
- Lexaria Bioscience Corp. showed an increase of +53.1% in Gross Profit compared to the prior fiscal year.
- Over the 2010–2025 period, Lexaria Bioscience Corp.’s gross profit has grown by 691.4% (from $88.9 thousand to $703.2 thousand).
- The most recent figure is from Lexaria Bioscience Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: